A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
Clinical trial NCT03861052 · COMPLETED
Trial details
- NCT number
- NCT03861052
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-07
- Primary completion
- 2021-03-10
- Enrollment
- 636
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.